Every week, Florida Medical Marijuana’s Office (OMMU) is part of the State Health Ministry, publishes data on the State Medical Cannabis program, including the calculation of the active patient, and updates for each operator. These data include number of dispenses and unit of unit each week. This is the fourteenth new Cannabis enterprises in Florida Medical Cannabis Market. On May 2024, May 2024, we published a newsletter about the state, offering readers Beware of FloridaA number of this article is based Update provided to 10/03 By the end of the end of 10/02. Readers who are interested in upcoming data can visit Ommu update pageA number
The patient’s growth has slowed down
The last time we refreshed in the Florida market in September and the annual growth of the patient’s calculation was 4.4% decreased by 4.3% after the last May last year. From March, the growth rate was collected a little, and it was again touched by the end of this last week from 10/02 to 4.6%. It has fallen a lot.
Although the number of patients is still growing, the growth is very low and significantly significantly a few years ago. The 926K patient represents 4% of the population of the state. The number of patients decreased before the possible legalization of adults, but recently increased at a new height.
The year ended about 895k patients and the growth rate was 3.5% since then. This works are underway for the annual growth of 4.6%, which exceeds 3.5% of 2024, but below the 11.0% increase in 2023.
Over the years, some program improvements have helped Florida residents of the Medical Cannabis, which now has a vessel flower and Swedes. Afterwards, the post-election epidemic population booms to help the patient’s growth. A year ago, the number of dispenses of 683 to 734 was registered. This is 7.5% growth, which is much faster than the growth of the medical cannabis’s patient is 4.6% since then. Looking at changes since the end of 2024, the open dispenser increased by 4.6%, and the patient’s calculation increased by about 3.5%.
Unit growth remains very strong
During the last week, the sale of medical cannabis products increased by 21.1% a year ago. The units of the floral flower were expanded by 14.6% after the end of 10/02/24. The increase in the unit remains higher than the acquisition of income and winning the patient. There are more shops, and the volume of the unit is growing.
We shared Florida’s income only by 1,4% to the beginning of a year, according to BDSA. This was then a record, but all historical data were reviewed by BDSA in September. The growth of April 2024 is now -40.8%, which seems to seem out of time. We reached BDSA, and they confirmed this income score, as the total number of 2021-2025 is now much lower. Looking at the revised data of 2025, the growth of Florida’s sales, as BDSA is predicted, the monthly annual growth is 6.8% (June). In Q3 it increased by 2.5% compared to the Q3 of 2024, and that 0.1% decreased in SeptemberThe growth of a number of patients and disponderable growth led to the growth of the unit, but the general sales only in Q3 was only marginal.
Florida MSOS is weak
We have warned the readers on May 17, 2024, in Blorida, as investors seemed too optimistic. Since then, the entire Cannabi market has spread, and the entire MSOS group is low, especially since the default of the adult’s ballotee’s initiative in November. All four Florida leaders have decreased significantly, despite the 10/09/25, especially the health of ayust, which made a big bet on the activities of the state.
The general sphere, measured by the NCV Global Cannabis stock index, last night, at 7.96, at 7.96, and the NCV American CANNABIS operator, which is now nine members and closed at 14.90. All Florida 4 have fallen over both. MSOS now has Curalef and Thutief by 47.1% of ETF decreased by 44.8%. Planet 13, which was acquired, which was forced by a large Florida player, decreased by 61.0%, which is better than four Florida leaders.
A year ago, many were waiting for Florida to legalize the cannabis for adult use, and operators expanded their dispensary calculation. While the majority of Florida’s voters have confirmed adult use, the means could not receive 60% of the required law. The year 2025 saw more dispensers, partially completed the planned plans for the failure of adult use. The market is fighting with slow growth of patients, open and competitive problems to raise dispenses (like sales sales). The result has been a flat income despite the growth of a strong unit.
Investors were disappointed that Florida voters did not pass the initiative to legalize adults, and they will most likely be pleased with a mature medical market that slows and becomes more competitive. Perhaps Florida will be legalized in 2026 for adult use, but from now on it has been a long time. Investors must be careful with the great Florida operators from our point of view. Although they have fallen significantly, they could fall more, because the market is deteriorating, especially the leader, which is located there, and the leader is in the state.
Based on the Houston, Alan cries out his experience as the founder of the online community 420 InvestorThe first and still the biggest decent diligent platform focused on the shares sold in the cannabis industry. Alan continues to find new ways to connect industry and facilitate its sustainable growth in the Canepuni community. Approximately New hemp enterprisesHe is responsible for content development and strategic alliances. Until the early 2013 focuses on the cannabis industry, Alan, who began his career in Wall Street, worked as more than two decades of research and portfolio. Article 650 of the Article 650 published in 2007 Looking for alphaWhere he has 70,000 followers, Alan is a frequent speaker for industry conferences and a Frequent source The media, including NY Times, Wall Street Journal, Fox Business and Bloomberg TV. Contact Alan. Ration | Facebook | Connection | Email
Michigan hemp sales for the month of December increased from a year ago as they rose 3.8% sequentially, which was +0.5% on a daily basis. At $269.7 million, sales increased by 1.6 percent compared to last year.
The Michigan Cannabis Regulatory Agency breaks down sales by medical and adult use, with medical sales down 50.2% year-over-year to $0.4 million, up 10.8% sequentially, and adult-use sales up 1.7% year-over-year to $269.3 million, up 3.8% sequentially.
The state breaks down sales by category and provides pricing details by category for both medical and adult;
For adultsMedical
As supply continues to expand, prices for adult flowers have plummeted. The average price of $932 a pound in December fell 2.6 percent sequentially to a new record low and fell 15.9 percent from a year earlier.
Michigan hemp sales are expected to grow 82.1% to $1.79 billion in 2021, 27.9% to $2.29 billion in 2022, and 33.3% to $3.06 billion in 2023. forward as supply becomes more accessible and distribution expands.
Based in Houston, Alan leverages his experience as an online community founder 420 Investorthe first and still the largest due diligence platform focused on publicly traded stocks in the cannabis industry. With his extensive network in the cannabis community, Alan continues to find new ways to connect the industry and facilitate its sustainable growth. time New Cannabis Ventureshe is responsible for content development and strategic alliances. Before turning his attention to the cannabis industry in early 2013, Alan, who began his career on Wall Street in 1986, worked as an independent research analyst with more than two decades of research and portfolio management experience. A prolific writer, with over 650 articles published since 2007 Looking for Alphawhere he has 70,000 followers, Alan is a frequent speaker at industry conferences and frequent source Media including the NY Times, Wall Street Journal, Fox Business and Bloomberg TV. Contact Alan. Twitter: |: Facebook |: LinkedIn: |: El
Each week, the Florida Office of Medical Marijuana Use (OMMU), part of the state Department of Health, releases data on the state’s medical cannabis program, including the number of active patients, the number of qualified physicians, new dispensary approvals and updates for each operator. That data includes the number of weekly dispensaries and unit sales. This is the sixteenth New Cannabis Ventures monthly update on the Florida medical cannabis market. We also published a newsletter about the state in May 2024, offering readers be careful with florida. This article is based on update provided on 01/02 by the state for the week ending 01/01. Readers interested in further data may visit OMMU update page.
Patient growth has slowed
We last updated on the Florida market in November, and year-over-year patient growth fell to 4.5%, down from 8.4% at the end of May a year ago. The growth rate picked up slightly from March, when it fell to just 3.0%, to 5.5% at the end of October. Year-on-year growth slowed again and it fell last week, ending 01/01 at 3.9%. It has dropped a lot.
Although the number of patients is still increasing, the increase is very low and has decreased significantly from just a few years ago. 930 thousand patients make up 4% of the population of the state. The number of cases was declining before the potential legalization of adult use, but has recently increased slightly to a new high;
The year 2024 ended with about 895 thousand patients, and after that the increase was 3.9%. The annual rate was higher than the 3.5% increase in 2024, which was affected by the expected increase in adult cannabis, but was well below the 11.0% increase in 2023.
Over the years, some program improvements have helped Florida residents get excited about the medical cannabis program, which now has smokable flower and edible products. Then, the post-epidemic population boom helped increase the number of patients. Outpatient clinics have increased, reaching 738 from 702 a year ago. That’s a 5.1% increase, slightly faster than the 3.9% increase in medical cannabis patients since then.
Unit growth remains very strong
In the last week, sales of medical cannabis products with THC increased by 23.7% compared to a year ago. Smokeable flower units expanded 17.7% from the week ending 01/02/25. Unit volume growth remains higher than revenue and patient gains. There are more stores and the volume of units is increasing.
We shared that Florida’s income grew just 1.4% from a year ago in April 2024, BDSA estimates. This was a record low at the time, but all historical data was revised by the BDSA for September. April 2024 growth is now reported at -40.8%, which seems a long way off. We contacted BDSA and they confirmed this revenue estimate as the 2021-2025 total is now much lower. Looking at revised 2025 data, Florida sales growth as projected by the BDSA has been volatile, with month-over-year growth ranging from -6.8% (April) to +17.2% (June). It increased by 0.4% in the third quarter compared to the third quarter of 2024, and it decreased by 3.4% in December. Patient growth and dispensary growth led to unit growth, but overall sales were down year-over-year.
Florida MSOs are weak
We warned readers on May 17, 2024 about large MSOs in Florida because investors seemed overly bullish. The entire cannabis market has been in turmoil since then, and the entire group of IPOs is down sharply, especially after the defeat of the adult-use ballot initiative in November. All four Florida leaders are down significantly though 10/09/25, especially AYR Wellness, which has been betting big on its operations in the state;
The overall sector, as measured by the NCV Global Cannabis Stock Index, at 6.68 last night, is down 38.3% since 01/05, and the NCV American Cannabis Operator Index, which currently has eleven members and closed at 12.74, is down 38,015/5%. Three of Florida’s 4 dropped more than both. MSOS, which has Curaleaf and Trulieve currently 46.0% of the ETF, is down 53.7% since 5/16/24 to $4.53 (below $4.57 NAV). Planet 13, an acquisition that made them a major player in Florida, dropped 67.3%, better than two of Florida’s four leaders.
Fourteen months ago, many expected Florida to legalize cannabis for adults, and operators were expanding their dispensaries. Although a majority of Florida voters approved adult use, the measure failed to receive the 60% required to change the law. There were more dispensaries in 2025, due in part to the completion of plans that were in place before adult-use legalization failed. The market is struggling with slow patient growth, dispensary growth and competitive issues (like sales of cannabis-derived THC). The result was flat revenue despite strong unit growth.
Investors were disappointed that Florida voters failed to pass an adult legalization ballot initiative, and they likely won’t be happy with a mature medical market that is slowing and becoming more competitive. Florida will probably legalize it for adult use in 2026, but that’s a long time away. Investors, in our view, should be wary of Florida’s major operators, especially the two that are in business through 2025.
Based in Houston, Alan leverages his experience as an online community founder 420 Investorthe first and still the largest due diligence platform focused on publicly traded stocks in the cannabis industry. With his extensive network in the cannabis community, Alan continues to find new ways to connect the industry and facilitate its sustainable growth. time New Cannabis Ventureshe is responsible for content development and strategic alliances. Before turning his attention to the cannabis industry in early 2013, Alan, who began his career on Wall Street in 1986, worked as an independent research analyst with more than two decades of research and portfolio management experience. A prolific writer, with over 650 articles published since 2007 Looking for Alphawhere he has 70,000 followers, Alan is a frequent speaker at industry conferences and frequent source Media including the NY Times, Wall Street Journal, Fox Business and Bloomberg TV. Contact Alan. Twitter: |: Facebook |: LinkedIn: |: El
New Cannabis Ventures offers readers this easy-to-read exclusive summary of BDSA’s 15-state monthly cannabis sales data.
Cannabis sales rose 2.9% sequentially in December, down 0.5% on the day. In this review, we break down the results by state, starting with the western markets and then ending with the eastern markets. Overall, BDSA estimates December sales in 15 markets totaled $2.14 billion, up 7.9 percent from a year ago, driven by strong growth in New York. BDSA updated its Illinois numbers after the state recently changed the way it counts sales.
Western markets
BDSA provides coverage for Arizona, California, Colorado, Nevada and Oregon. In December, annual growth was negative in 4 states. In three of these states, daily growth fell sequentially.
Eastern markets
BDSA provides coverage for Florida, Illinois, Maryland, Massachusetts, Michigan, Missouri, New Jersey, New York, Ohio and Pennsylvania. In December, year-over-year growth ranged from -3.5% in Maryland to +1,172.2% in New York, where adult sales were included by the BDSA beginning in January, but were first included several months ago. Ohio began using adults in August, spurring growth. Note that Florida and Pennsylvania are medical markets only. On a daily basis, sequential gains declined in five markets. Annual growth was negative in several markets and increased sharply in two states. We warned of a potential slowdown in Florida despite strong dispensary and unit volume growth due to competitive pressure, and it declined in four months of 2025, including three in the final four months of the year.
For readers interested in a deeper look hemp markets in these fifteen states and more, including segmentation by additional product categories, brand and product details, longer history and segmentation by product attributes, learn how BDSA Solutions can give you access to actionable data and analytics.
Based in Houston, Alan leverages his experience as an online community founder 420 Investorthe first and still the largest due diligence platform focused on publicly traded stocks in the cannabis industry. With his extensive network in the cannabis community, Alan continues to find new ways to connect the industry and facilitate its sustainable growth. time New Cannabis Ventureshe is responsible for content development and strategic alliances. Before turning his attention to the cannabis industry in early 2013, Alan, who began his career on Wall Street in 1986, worked as an independent research analyst with more than two decades of research and portfolio management experience. A prolific writer, with over 650 articles published since 2007 Looking for Alphawhere he has 70,000 followers, Alan is a frequent speaker at industry conferences and frequent source Media including the NY Times, Wall Street Journal, Fox Business and Bloomberg TV. Contact Alan. Twitter: |: Facebook |: LinkedIn: |: El
